Tevogen Bio Inc.
TVGN | NASDAQ
$6.00
+$0.10 (+1.69%)
Nov 2, 2026, 10:37 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -21.61M | -21.35M | -26.28M | -30.85M | -31.01M | -35.16M | -13.53M | -7.92M | -5.94M | -18.46M | -60.48M | -62.57M | -63.55M | -41.16M | -10.43M | -4.72M | 163.68K | -43.32K | -17.33K |
Depreciation & Amortization | 232.21K | 198.65K | 245.01K | 526.96K | 454.47K | 410.68K | 403.58K | 400.9K | 275.55K | 385.45K | 378.36K | 473.55K | 382.06K | 289.36K | 198.15K | 2.1K | n/a | n/a | n/a |
Stock-Based Compensation | 11.83M | 11.78M | 16.22M | 13.78M | 13.86M | 14.76M | 33.8M | 33.8M | 30.48M | 26.33M | n/a | 720.82K | 1.98M | 1.98M | 1.98M | 1.26M | n/a | n/a | n/a |
Other Working Capital | -1.38M | -1.57M | -760.38K | -1.45M | -1.67M | -964.11K | -2.33M | -1.79M | -1.34M | -1.26M | -526.9K | 109.93K | -88.35K | 154.96K | 676.86K | -322.26K | -249.25K | -491.56K | -571.78K |
Other Non-Cash Items | -92.91K | 166.94K | 203.49K | 6.79M | 6.8M | 7.72M | -32.67M | -37.89M | -35.99M | -17.18M | 51.64M | 51.66M | 51.77M | 31.3M | 2.61M | 806.32K | -885.64K | -420.05K | -163.16K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.93M | -2.55M | -2.72M | -3.44M | -3.46M | -873.15K | -5.49K | 675.45K | 2.26M | 755.24K | 293.21K | 788.66K | 284.27K | 622.82K | 736.86K | -223.81K | -150.8K | -363.49K | -533.33K |
Operating Cash Flow | -11.57M | -11.75M | -12.33M | -13.19M | -13.35M | -13.14M | -12M | -10.93M | -8.92M | -8.16M | -8.17M | -8.93M | -9.14M | -6.97M | -4.9M | -2.88M | -872.76K | -826.86K | -713.83K |
Capital Expenditures | -64.43K | -64.43K | -64.42K | 6 | 1 | -2 | n/a | 6 | 9 | 8 | -133K | -298.39K | -425.02K | -425.02K | -292.03K | -126.65K | -10 | -9 | -4 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -351.9M | -351.9M | -351.9M | -351.9M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -64.44K | -64.44K | -64.44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -133K | -298.39K | -425.02K | -425.02K | -292.02K | -352.03M | -351.9M | -351.9M | -351.9M |
Debt Repayment | 2M | 3.4M | 3.4M | 3.4M | 4.4M | 3M | 1M | 1.35M | 1.5M | 1.5M | 4M | 6.15M | 5M | 5M | 2.5M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1M | 1.5M | 1.5M | 1.5M | 500K | n/a | 229.33K | 229.33K | 229.33K | 229.33K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 12.03M | 10.54M | 11.66M | 11.9M | 12.9M | 13.8M | 12.23M | 10.65M | 6.6M | 3.8M | 3.87M | 5.95M | 5M | 5M | 2.5M | 352.96M | 352.96M | 352.96M | 352.96M |
Net Cash Flow | 396.93K | -1.28M | -730.62K | -1.29M | -450.16K | 657.03K | 230.6K | 1.98M | 579.38K | 1.27M | 1.19M | 82.93K | -1.84M | -2.39M | -2.69M | -1.95M | 185.65K | 231.55K | 344.58K |
Free Cash Flow | -11.63M | -11.82M | -12.39M | -13.19M | -13.35M | -13.14M | -12M | -10.93M | -8.92M | -8.16M | -8.3M | -9.23M | -9.56M | -7.39M | -5.19M | -3.01M | -872.77K | -826.87K | -713.83K |
Adj. Free Cash Flow | -23.46M | -23.6M | -28.62M | -26.97M | -27.21M | -27.91M | -45.8M | -44.73M | -39.4M | -34.49M | -8.3M | -9.95M | -11.54M | -9.37M | -7.17M | -4.26M | -872.77K | -826.87K | -713.83K |
Maintenance CapEx | -64.44K | -64.44K | -64.44K | -14 | -11 | -8 | -10 | -8 | -9 | -10 | -91.21K | -256.6K | -258.69K | -258.69K | -167.48K | -2.1K | n/a | n/a | n/a |
Growth CapEx | 14 | 14 | 20 | 20 | 12 | 6 | 10 | 14 | 18 | 18 | -41.78K | -41.79K | -166.33K | -166.33K | -124.55K | -124.55K | n/a | n/a | n/a |
Owner Earnings | -11.63M | -11.82M | -12.39M | -13.2M | -13.35M | -13.14M | -12M | -10.93M | -8.92M | -8.16M | -8.26M | -9.19M | -9.4M | -7.23M | -5.07M | -2.88M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TVGN